DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE (disorder)
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
HPCA confirmed as a genetic cause of DYT2-like dystonia phenotype.
|
30145809 |
2018 |
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE (disorder)
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Biophysical and functional characterization of hippocalcin mutants responsible for human dystonia.
|
28398555 |
2017 |
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE (disorder)
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in HPCA cause autosomal-recessive primary isolated dystonia.
|
25799108 |
2015 |
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE (disorder)
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in HPCA cause autosomal-recessive primary isolated dystonia.
|
25799108 |
2015 |
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE (disorder)
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in HPCA cause autosomal-recessive primary isolated dystonia.
|
25799108 |
2015 |
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE (disorder)
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in HPCA cause autosomal-recessive primary isolated dystonia.
|
25799108 |
2015 |
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE (disorder)
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE (disorder)
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Dystonia Musculorum Deformans
|
0.110 |
Biomarker
|
disease |
BEFREE |
Autosomal recessive, DYT2-like primary torsion dystonia: a new family.
|
14694054 |
2003 |
Dystonia Musculorum Deformans
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Blepharospasm
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Deglutition Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Torticollis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Tremor
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Feeding difficulties
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Difficulty walking
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dystonia, Limb
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Generalized dystonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Slow progression
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dystonia
|
0.070 |
GeneticVariation
|
phenotype |
BEFREE |
In conclusion, our study identifies sAHP as a downstream cellular target perturbed by N75K mutation in DYT2 dystonia, demonstrates its impact on neuronal excitability, and suggests a potential therapeutic strategy to efficiently treat DYT2.
|
31301343 |
2019 |
Dystonia Disorders
|
0.070 |
GeneticVariation
|
group |
BEFREE |
In conclusion, our study identifies sAHP as a downstream cellular target perturbed by N75K mutation in DYT2 dystonia, demonstrates its impact on neuronal excitability, and suggests a potential therapeutic strategy to efficiently treat DYT2.
|
31301343 |
2019 |
Dystonia
|
0.070 |
GeneticVariation
|
phenotype |
BEFREE |
Our findings confirm that HPCA leads to recessively inherited dystonia.
|
30145809 |
2018 |
Dystonia Disorders
|
0.070 |
GeneticVariation
|
group |
BEFREE |
Our findings confirm that HPCA leads to recessively inherited dystonia.
|
30145809 |
2018 |
Dystonia
|
0.070 |
GeneticVariation
|
phenotype |
BEFREE |
None of the patients enrolled was found to carry HPCA mutations, rising suspicion that these probably represent a very rare cause of dystonia in childhood-adolescence.
|
27771228 |
2017 |